Nasdaq: $25.89 (-0.35) | AIM: £3.75 (+0.05)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
监管信息公告, 肿瘤学 / 免疫学 | 2007-06-18

Chi-Med locks-in property gain and protects low cost R&D structure through acquisition of Shanghai facility